Novel integrase-defective lentiviral episomal vectors for gene transfer

Human Gene Therapy

Volumn 15, Issue 4, 2004, Pages 361-372

  Vargas Jr , J ^a   Gusella, G L ^a   Najfeld, V ^a   Klotman, M E ^a   Cara, A ^b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EXTRACHROMOSOMAL DNA; GLIAL FIBRILLARY ACIDIC PROTEIN; INTEGRASE; LENTIVIRUS VECTOR; LUCIFERASE; VIRUS LARGE T ANTIGEN;

ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS; DNA INTEGRATION; DNA REPLICATION ORIGIN; EPISOME; FLUORESCENCE IN SITU HYBRIDIZATION; GENE INSERTION; HUMAN; HUMAN CELL; LONG TERMINAL REPEAT; POLYMERASE CHAIN REACTION; PROMOTER REGION; REPORTER GENE; SIMIAN VIRUS 40; SUICIDE GENE; VIRAL GENE DELIVERY SYSTEM;

CELLS, CULTURED; CYTOMEGALOVIRUS; DEFECTIVE VIRUSES; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; INTEGRASES; KIDNEY; LENTIVIRUS; LUCIFERASES; LUMINESCENT PROTEINS; POLYMERASE CHAIN REACTION; SIMIAN VIRUS 40; TERMINAL REPEAT SEQUENCES; TRANSDUCTION, GENETIC; TRANSFECTION; TRANSGENES;

CUCUMBER MOSAIC VIRUS; CYTOMEGALOVIRUS; DNA VIRUSES; INSERTION SEQUENCES; LENTIVIRUS; PAPILLOMAVIRUS; POLYOMAVIRUS; SIMIAE; SIMIAN VIRUS 40;

EID: 1842686860     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/104303404322959515     Document Type: Article

References (55)

1. ANSARI-LARI, M.A., DONEHOWER, L.A., and GIBBS, R.A. (1995). Analysis of human immunodeficiency virus type 1 integrase mutants. Virology 213, 680.
2. BELL, P., MONTANER, L.J., and MAUL, G.G. (2001). Accumulation and intranuclear distribution of unintegrated human immunodeficiency virus type 1 DNA. J. Virol. 75, 7683-7691.
3. BERGER, J.R., and MAJOR, E.O. (1999). Progressive multifocal leukoencephalopathy. Semin. Neurol. 19, 193-200.
4. BLOMER, U., NALDINI, L., KAFRI, T., TRONO, D., VERMA, I.M., and GAGE, F.H. (1997). Highly efficient and sustained gene transfer in adult neurons with a lentivirus vector. J. Virol. 71, 6641-6649.
5. BROWN, P.O., BOWERMAN, B., VARMUS, H.E., and BISHOP, J.M. (1987). Correct integration of retroviral DNA in vitro. Cell 49, 347-356.
6. BUKRINSKY, M.I., SHAROVA, N., DEMPSEY, M.P., STANWICK, T.L., BUKRINSKAYA, A.G., HAGGERTY, S., and STEVENSON, M. (1992). Active nuclear import of human immunodeficiency virus type 1 preintegration complexes. Proc. Natl. Acad. Sci. U.S.A. 89, 6580-6584.
7. BUTLER, S.L., HANSEN, M.S., and BUSHMAN, F.D. (2001). A quantitative assay for HIV DNA integration in vivo. Nat. Med. 7, 631-634.
8. BUTLER, S.L., JOHNSON, E.P., and BUSHMAN, F.D. (2002). Human immunodeficiency virus cDNA metabolism: Notable stability of two-long terminal repeat circles. J. Virol. 76, 3739-3747.
9. CALOS, M.P. (1996). The potential of extrachromosomal replicating vectors for gene therapy. Trends Genet. 12, 463-466.
10. CARA, A., and REITZ, M.S., JR. (1997). New insight on the role of extrachromosomal retroviral DNA. Leukemia 11, 1395-1399.
11. CARA, A., GUARNACCIA, F., REITZ, M.S., GALLO, R.C., and LORI, F. (1995). Self-limiting, cell type-dependent replication of an integrase-defective human immunodeficiency virus type 1 in human primary macrophages but not T lymphocytes. Virology 208, 242-248.
12. CARA, A., CERESETO, A., LORI, F., and REITZ, M.S., JR. (1996). HIV-1 protein expression from synthetic circles of DNA mimicking the extrachromosomal forms of viral DNA. J. Biol. Chem. 271, 5393-5397.
13. CHIU, I.M., TOUHALISKY, K., LIU, Y., YATES, A., and FROSTHOLM, A. (2000). Tumorigenesis in transgenic mice in which the SV40 T antigen is driven by the brain-specific FGF1 promoter. Oncogene 19, 6229-6239.
14. COLE, C.N. (1996). Polyomavirinae: The viruses and their replication. In Fundamental Virology, 3rd Ed. B.N. Fields, D.M. Knipe, and P.M. Howley, eds. (Lippincott-Raven, Philadelphia) pp. 914-946.
15. DEPAMPHILIS, M.L., and WASSERMAN, P.M. (1982). Organization and replication of papovavirus DNA. In Organization and Replication of Viral DNA. A.S. Kaplan, ed. (CRC Press, Boca Raton, FL) pp. 37-114.
16. ENGELMAN, A., ENGLUND, G., ORENSTEIN, J.M., MARTIN, M.A., and CRAIGIE, R. (1995). Multiple effects of mutations in human immunodeficiency virus type 1 integrase on viral replication. J. Virol. 69, 2729-2736.
17. FARNET, C.M., and HASELTINE, W.A. (1991). Circularization of human immunodeficiency virus type 1 DNA in vitro. J. Virol. 65, 6942-6952.
18. HAAS, S., HAQUE, N.S., BEGGS, A.H., KHALILI, K., KNOBLER, R.L., and SMALL, J. (1994). Expression of the myelin basic protein gene in transgenic mice expressing human neurotropic virus, JCV, early protein. Virology 202, 89-96.
19. HACEIN-BEY-ABINA, S., LE DEIST, F., CARLIER, F., BOUNEAUD, C., HUE, C., DE VILLARTAY, J.P., THRASHER, A.J., WULFFRAAT, N., SORENSEN, R., DUPUIS-GIROD, S., FISCHER, A., DAVIES, E.G., KUIS, W., LEIVA, L., and CAVAZZANA-CALVO, M. (2002). Sustained correction of X-linked severe combined immunodeficiency by ex vivo gene therapy. N. Engl. J. Med. 346, 1185-1193.
20. HACEIN-BEY-ABINA, S., VON KALLE, C., SCHMIDT, M., LE DEIST, F., WULFFRAAT, N., MCINTYRE, E., RADFORD, I., VILLEVAL, J.L., FRASER, C.C., CAVAZZANA-CALVO, M., and FISCHER, A. (2003). A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency. N. Engl. J. Med. 348, 255-256.
21. HOWLEY, P. (1996). Papillomavarinae: The viruses and their replication. In Fundamental Virology, 3rd Ed. B.N. Fields, D.M. Knipe, and P.M. Howley, eds. (Lippincott-Raven, Philadelphia) pp. 947-978.
22. KAFRI, T., BLOMER, U., PETERSON, D.A., GAGE, F.H., and VERMA, I.M. (1997). Sustained expression of genes delivered directly into liver and muscle by lentiviral vectors. Nat. Genet. 17, 314-317.
23. KONG, F., CHEN, C.H., and COOPER, M.D. (1998). Thymic function can be accurately monitored by the level of recent T cell emigrants in the circulation. Immunity 8, 97-104.
24. LI, L., OLVERA, J.M., YODER, K.E., MITCHELL, R.S., BUTLER, S.L., LIEBER, M., MARTIN, S.L., and BUSHMAN, F.D. (2001). Role of the non-homologous DNA end joining pathway in the early steps of retroviral infection. EMBO J. 20, 3272-3281.
25. LI, Z., DULLMANN, J., SCHIEDLMEIER, B., SCHMIDT, M., VON KALLE, C., MEYER, J., FORSTER, M., STOCKING, C., WAHLERS, A., FRANK, O., OSTERTAG, W., KUHLCKE, K., ECKERT, H. G., FEHSE, B., and BAUM, C. (2002). Murine leukemia induced by retroviral gene marking. Science 296, 497.
26. DJ recombination by-products are abundant in thymocytes and mature T cells. Mol. Cell. Biol. 16, 609-618.
27. MCCANCE, D.J. (1986). Human papillomavirus and cancer. Biochim. Biophys. Acta 823, 195-205.
28. MILLER, A.D. (1992). Human gene therapy comes of age. Nature 357, 455-460.
29. MULLIGAN, R.C. (1993). The basic science of gene therapy. Science 260, 926-932.
30. NAJFELD, V., MENNINGER, J., BALLARD, S.G., DEGUCHI, Y., WARD, D.C., and KEHRL, J.H. (1992). Two diverged human homeobox genes involved in the differentiation of human hematopoietic progenitors map to chromosome 1, bands q41-42.1. Genes Chromosomes Cancer 5, 343-347.
31. NALDINI, L., and VERMA, I.M. (2000). Lentiviral vectors. Adv. Virus Res. 55, 599-609.
32. NALDINI, L., BLOMER, U., GAGE, F.H., TRONO, D., and VERMA, I.M. (1996a). Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector. Proc. Natl. Acad. Sci. U.S.A. 93, 11382-11388.
33. NALDINI, L., BLOMER, U., GALLAY, P., ORY, D., MULLIGAN, R., GAGE, F.H., VERMA, I.M., and TRONO, D. (1996b). In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 272, 263-267.
34. NAVIAUX, R.K., and VERMA, I.M. (1992). Retroviral vectors for persistent expression in vivo. Curr. Opin. Biotechnol. 3, 540-547.
35. PAGANO, J.S. (1999). Epstein-Barr virus: The first human tumor virus and its role in cancer. Proc. Assoc. Am. Physicians 111, 573-580.
36. PAUZA, C.D., TRIVEDI, P., MCKECHNIE, T.S., RICHMAN, D.D., and GRAZIANO, F.M. (1994). 2-LTR circular viral DNA as a marker for human immunodeficiency virus type 1 infection in vivo. Virology 205, 470-478.
37. PIERSON, T.C., KIEFFER, T.L., RUFF, C.T., BUCK, C., GANGE, S.J., and SILICIANO, R.F. (2002). Intrinsic stability of episomal circles formed during human immunodeficiency virus type 1 replication. J. Virol. 76, 4138-4144.
38. SAMBROOK, J., FRITSCH, E.F., and MANIATIS, T. (1986). Molecular Cloning: A Laboratory Manual, 2nd Ed. (Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY).
39. SCHRODER, A.R., SHINN, P., CHEN, H., BERRY, C., ECKER, J.R., and BUSHMAN, F. (2002). HIV-1 integration in the human genome favors active genes and local hotspots. Cell 110, 521-529.
40. SCLIMENTI, C.R., and CALOS, M.P. (1998). Epstein-Barr virus vectors for gene expression and transfer. Curr. Opin. Biotechnol. 9, 476-479.
41. SCLIMENTI, C.R., NEVIASER, A.S., BABA, E.J., MEUSE, L., KAY, M.A., and CALOS, M.P. (2003). Epstein-Barr virus vectors provide prolonged robust factor IX expression in mice. Biotechnol. Prog. 19, 144-151.
42. SNYDER, R.O., SPRATT, S.K., LAGARDE, C., BOHL, D., KASPAR, B., SLOAN, B., COHEN, L.K., and DANOS, O. (1997). Efficient and stable adeno-associated virus-mediated transduction in the skeletal muscle of adult immunocompetent mice. Hum. Gene Ther. 8, 1891-900.
43. SONZA, S., KIERNAN, R.E., MAERZ, A.L., DEACON, N.J., MCPHEE, D.A., and CROWE, S.M. (1994). Accumulation of unintegrated circular viral DNA in monocytes and growth-arrested T cells following infection with HIV-1. J. Leukoc. Biol. 56, 289-293.
44. STEVENSON, M., HAGGERTY, S., LAMONICA, C.A., MEIER, C.M., WELCH, S.K., and WASIAK, A.J. (1990). Integration is not necessary for expression of human immunodeficiency virus type 1 protein products. J. Virol. 64, 2421-2425.
45. STOCKING, C., BERGHOLZ, U., FRIEL, J., KLINGLER, K., WAGENER, T., STARKE, C., KITAMURA, T., MIYAJIMA, A., and OSTERTAG, W. (1993). Distinct classes of factor-independent mutants can be isolated after retroviral mutagenesis of a human myeloid stem cell line. Growth Factors 8, 197-209.
46. STRAYER, D.S. (1996). SV40 as an effective gene transfer vector in vivo. J. Biol. Chem. 271, 24741-24746.
47. STRAYER, D.S., and MILANO, J. (1996). SV40 mediates stable gene transfer in vivo. Gene Ther. 3, 581-587.
48. TADDEO, B., HASELTINE, W.A., and FARNET, C.M. (1994). Integrase mutants of human immunodeficiency virus type 1 with a specific defect in integration. J. Virol. 68, 8401-8405.
49. TAKESHITA, S., TODA, M., and YAMAGISHI, H. (1989). Excision products of the T cell receptor gene support a progressive rearrangement model of the α/δ locus. EMBO J. 8, 3261-3270.
50. VANIN, E.F., KALOSS, M., BROSCIUS, C., and NIENHUlS, A.W. (1994). Characterization of replication-competent retroviruses from nonhuman primates with virus-induced T-cell lymphomas and observations regarding the mechanism of oncogenesis. J. Virol. 68, 4241-4250.
51. VARMUS, H.E., and SWANSTROM, R. (1984). Replication of retroviruses. In RNA Tumor Viruses. J. Coffin, ed. (Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY) pp. 75-134.
52. VERMA, I.M., and SOMIA, N. (1997). Gene therapy: Promises, problems and prospects. Nature 389, 239-242.
53. WISKERCHEN, M., and MUESING, M.A. (1995). Human immunodeficiency virus type 1 integrase: Effects of mutations on viral ability to integrate, direct viral gene expression from unintegrated viral DNA templates, and sustain viral propagation in primary cells. J. Virol. 69, 376-386.
54. WOHLGEMUTH, J.G., KANG, S.H., BULBOACA, G.H., NAWOTKA, K.A., and CALOS, M.P. (1996). Long-term gene expression from autonomously replicating vectors in mammalian cells. Gene Ther. 3, 503-512.
55. WU, X., LI, Y., CRISE, B., and BURGESS, S.M. (2003). Transcription start regions in the human genome are favored targets for MLV integration. Science 300, 1749-1751.